Dirui Industrial Co

Dirui Industrial Co EBITDA per Employee

The EBITDA per Employee of Dirui Industrial Co (300396.SZ) as of Nov 5, 2026 is -46,512.40 CNY. In the previous year, EBITDA per Employee was 93,598.10 CNY — a change of -149.69% (lower).

EBITDA per Employee

-46,512.40CNY

YoY

-149.69%

Last updated:

EBITDA per Employee of Dirui Industrial Co is 2025 -46,512.40 CNY. EBITDA per Employee of Dirui Industrial Co was 2024 93,598.10 CNY. It decreases by -149.69% lower compared to the previous year.

The Dirui Industrial Co EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
173,976.97 CNY
Jan 1, 2019
192,983.86 CNY
Jan 1, 2020
189,263.84 CNY
Jan 1, 2021
136,414.73 CNY
Jan 1, 2022
169,529.97 CNY
Jan 1, 2023
172,914.57 CNY
Jan 1, 2024
93,598.10 CNY
Jan 1, 2025
-46,512.40 CNY
The Dirui Industrial Co EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-46,512.40CNY-149.69%
93,598.10CNY-45.87%
172,914.57CNY+2.00%
169,529.97CNY+24.28%
136,414.73CNY-27.92%
189,263.84CNY-1.93%
192,983.86CNY+10.92%
173,976.97CNY+16.77%
148,989.12CNY+36.92%
108,811.41CNY+52.08%
71,551.00CNY+30.26%
54,928.57CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dirui Industrial Co Stock analysis

What does Dirui Industrial Co do? Dirui Industrial Co., Ltd. generates revenue through the research, development, production, and sale of medical testing instruments and supporting test paper reagents. The company's main products include urine analysis series, urinary composition analysis series, biochemical analysis series, and blood cell analysis series, which are used for routine physical examinations and diagnosis of illness. Domestic and overseas markets are the primary distribution channels for these products, with the firm targeting healthcare providers and diagnostic laboratories that require reliable testing solutions for patient care. The company's product portfolio focuses on diagnostic tools essential for clinical settings, serving both domestic and international healthcare sectors. By offering a comprehensive range of testing instruments and reagents, Dirui Industrial addresses the needs of medical facilities seeking efficient and accurate diagnostic capabilities. The firm's products are integral to routine health screenings and medical diagnostics, supporting healthcare professionals in patient assessment and treatment planning. Dirui Industrial's business model relies on direct sales to healthcare institutions and distributors operating within domestic and overseas markets. The company's products are positioned as essential diagnostic tools for routine physical examinations and illness diagnosis, appealing to a broad spectrum of medical practitioners and facilities. This approach ensures consistent demand for their instruments and reagents across various healthcare environments. Dirui Industrial Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dirui Industrial Co stock

EBITDA per Employee of Dirui Industrial Co is -46,512.40 CNY in 2025.

EBITDA per Employee of Dirui Industrial Co changed from 93,598.10 CNY to -46,512.40 CNY, representing a -149.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Dirui Industrial Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Dirui Industrial Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Dirui Industrial Co

All Key Metrics — Dirui Industrial Co